Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Gala introduces a groundbreaking digital health platform that ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Preliminary research shows that taking medication like Zepbound and Wegovy can help patients reduce their risk for dementia and pneumonia.

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...